[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Human Coagulation Factor VIII Market - Global Outlook and Forecast 2021-2027

March 2021 | 109 pages | ID: H0BA6C7CC58CEN
Market Monitor Global

US$ 3,250.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
This report contains market size and forecasts of Human Coagulation Factor VIII in global, including the following market information:

Global Human Coagulation Factor VIII Market Revenue, 2016-2021, 2022-2027, ($ millions)

Global Human Coagulation Factor VIII Market Sales, 2016-2021, 2022-2027, (Kg)

Global top five Human Coagulation Factor VIII companies in 2020 (%)

The global Human Coagulation Factor VIII market was valued at 8403.7 million in 2020 and is projected to reach US$ 9411.2 million by 2027, at a CAGR of 2.9% during the forecast period.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Human Coagulation Factor VIII manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Human Coagulation Factor VIII Market, By Type, 2016-2021, 2022-2027 ($ Millions) & (Kg)

Global Human Coagulation Factor VIII Market Segment Percentages, By Type, 2020 (%)
  • Recombinant Factor VIII
  • Plasma-derived Factor VIII
Global Human Coagulation Factor VIII Market, By Application, 2016-2021, 2022-2027 ($ Millions) & (Kg)

Global Human Coagulation Factor VIII Market Segment Percentages, By Application, 2020 (%)
  • Hemophilia A
  • Spontanous / Trauma
  • Surgical
  • Other
Global Human Coagulation Factor VIII Market, By Region and Country, 2016-2021, 2022-2027 ($ Millions) & (Kg)

Global Human Coagulation Factor VIII Market Segment Percentages, By Region and Country, 2020 (%)
  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • U.K.
    • Italy
    • Russia
    • Nordic Countries
    • Benelux
    • Rest of Europe
  • Asia
    • China
    • Japan
    • South Korea
    • Southeast Asia
    • India
    • Rest of Asia
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Middle East & Africa
    • Turkey
    • Israel
    • Saudi Arabia
    • UAE
    • Rest of Middle East & Africa
Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Human Coagulation Factor VIII revenues in global market, 2016-2021 (Estimated), ($ millions)

Key companies Human Coagulation Factor VIII revenues share in global market, 2020 (%)

Key companies Human Coagulation Factor VIII sales in global market, 2016-2021 (Estimated), (Kg)

Key companies Human Coagulation Factor VIII sales share in global market, 2020 (%)

Further, the report presents profiles of competitors in the market, key players include:
  • Shire (Baxter)
  • Bayer
  • CSL
  • Pfizer
  • Grifols
  • Biogen
  • Octapharma
  • NovoNordisk
  • Greencross
  • Kedrion
  • BPL
  • Hualan Bio
  • RAAS
1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Human Coagulation Factor VIII Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Human Coagulation Factor VIII Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL HUMAN COAGULATION FACTOR VIII OVERALL MARKET SIZE

2.1 Global Human Coagulation Factor VIII Market Size: 2021 VS 2027
2.2 Global Human Coagulation Factor VIII Revenue, Prospects & Forecasts: 2016-2027
2.3 Global Human Coagulation Factor VIII Sales (Consumption): 2016-2027

3 COMPANY LANDSCAPE

3.1 Top Human Coagulation Factor VIII Players in Global Market
3.2 Top Global Human Coagulation Factor VIII Companies Ranked by Revenue
3.3 Global Human Coagulation Factor VIII Revenue by Companies
3.4 Global Human Coagulation Factor VIII Sales by Companies
3.5 Global Human Coagulation Factor VIII Price by Manufacturer (2016-2021)
3.6 Top 3 and Top 5 Human Coagulation Factor VIII Companies in Global Market, by Revenue in 2020
3.7 Global Manufacturers Human Coagulation Factor VIII Product Type
3.8 Tier 1, Tier 2 and Tier 3 Human Coagulation Factor VIII Players in Global Market
  3.8.1 List of Global Tier 1 Human Coagulation Factor VIII Companies
  3.8.2 List of Global Tier 2 and Tier 3 Human Coagulation Factor VIII Companies

4 SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 By Type - Global Human Coagulation Factor VIII Market Size Markets, 2021 & 2027
  4.1.2 Recombinant Factor VIII
  4.1.3 Plasma-derived Factor VIII
4.2 By Type - Global Human Coagulation Factor VIII Revenue & Forecasts
  4.2.1 By Type - Global Human Coagulation Factor VIII Revenue, 2016-2021
  4.2.2 By Type - Global Human Coagulation Factor VIII Revenue, 2022-2027
  4.2.3 By Type - Global Human Coagulation Factor VIII Revenue Market Share, 2016-2027
4.3 By Type - Global Human Coagulation Factor VIII Sales & Forecasts
  4.3.1 By Type - Global Human Coagulation Factor VIII Sales, 2016-2021
  4.3.2 By Type - Global Human Coagulation Factor VIII Sales, 2022-2027
  4.3.3 By Type - Global Human Coagulation Factor VIII Sales Market Share, 2016-2027
4.4 By Type - Global Human Coagulation Factor VIII Price (Manufacturers Selling Prices), 2016-2027

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Human Coagulation Factor VIII Market Size, 2021 & 2027
  5.1.2 Hemophilia A
  5.1.3 Spontanous / Trauma
  5.1.4 Surgical
  5.1.5 Other
5.2 By Application - Global Human Coagulation Factor VIII Revenue & Forecasts
  5.2.1 By Application - Global Human Coagulation Factor VIII Revenue, 2016-2021
  5.2.2 By Application - Global Human Coagulation Factor VIII Revenue, 2022-2027
  5.2.3 By Application - Global Human Coagulation Factor VIII Revenue Market Share, 2016-2027
5.3 By Application - Global Human Coagulation Factor VIII Sales & Forecasts
  5.3.1 By Application - Global Human Coagulation Factor VIII Sales, 2016-2021
  5.3.2 By Application - Global Human Coagulation Factor VIII Sales, 2022-2027
  5.3.3 By Application - Global Human Coagulation Factor VIII Sales Market Share, 2016-2027
5.4 By Application - Global Human Coagulation Factor VIII Price (Manufacturers Selling Prices), 2016-2027

6 SIGHTS BY REGION

6.1 By Region - Global Human Coagulation Factor VIII Market Size, 2021 & 2027
6.2 By Region - Global Human Coagulation Factor VIII Revenue & Forecasts
  6.2.1 By Region - Global Human Coagulation Factor VIII Revenue, 2016-2021
  6.2.2 By Region - Global Human Coagulation Factor VIII Revenue, 2022-2027
  6.2.3 By Region - Global Human Coagulation Factor VIII Revenue Market Share, 2016-2027
6.3 By Region - Global Human Coagulation Factor VIII Sales & Forecasts
  6.3.1 By Region - Global Human Coagulation Factor VIII Sales, 2016-2021
  6.3.2 By Region - Global Human Coagulation Factor VIII Sales, 2022-2027
  6.3.3 By Region - Global Human Coagulation Factor VIII Sales Market Share, 2016-2027
6.4 North America
  6.4.1 By Country - North America Human Coagulation Factor VIII Revenue, 2016-2027
  6.4.2 By Country - North America Human Coagulation Factor VIII Sales, 2016-2027
  6.4.3 US Human Coagulation Factor VIII Market Size, 2016-2027
  6.4.4 Canada Human Coagulation Factor VIII Market Size, 2016-2027
  6.4.5 Mexico Human Coagulation Factor VIII Market Size, 2016-2027
6.5 Europe
  6.5.1 By Country - Europe Human Coagulation Factor VIII Revenue, 2016-2027
  6.5.2 By Country - Europe Human Coagulation Factor VIII Sales, 2016-2027
  6.5.3 Germany Human Coagulation Factor VIII Market Size, 2016-2027
  6.5.4 France Human Coagulation Factor VIII Market Size, 2016-2027
  6.5.5 U.K. Human Coagulation Factor VIII Market Size, 2016-2027
  6.5.6 Italy Human Coagulation Factor VIII Market Size, 2016-2027
  6.5.7 Russia Human Coagulation Factor VIII Market Size, 2016-2027
  6.5.8 Nordic Countries Human Coagulation Factor VIII Market Size, 2016-2027
  6.5.9 Benelux Human Coagulation Factor VIII Market Size, 2016-2027
6.6 Asia
  6.6.1 By Region - Asia Human Coagulation Factor VIII Revenue, 2016-2027
  6.6.2 By Region - Asia Human Coagulation Factor VIII Sales, 2016-2027
  6.6.3 China Human Coagulation Factor VIII Market Size, 2016-2027
  6.6.4 Japan Human Coagulation Factor VIII Market Size, 2016-2027
  6.6.5 South Korea Human Coagulation Factor VIII Market Size, 2016-2027
  6.6.6 Southeast Asia Human Coagulation Factor VIII Market Size, 2016-2027
  6.6.7 India Human Coagulation Factor VIII Market Size, 2016-2027
6.7 South America
  6.7.1 By Country - South America Human Coagulation Factor VIII Revenue, 2016-2027
  6.7.2 By Country - South America Human Coagulation Factor VIII Sales, 2016-2027
  6.7.3 Brazil Human Coagulation Factor VIII Market Size, 2016-2027
  6.7.4 Argentina Human Coagulation Factor VIII Market Size, 2016-2027
6.8 Middle East & Africa
  6.8.1 By Country - Middle East & Africa Human Coagulation Factor VIII Revenue, 2016-2027
  6.8.2 By Country - Middle East & Africa Human Coagulation Factor VIII Sales, 2016-2027
  6.8.3 Turkey Human Coagulation Factor VIII Market Size, 2016-2027
  6.8.4 Israel Human Coagulation Factor VIII Market Size, 2016-2027
  6.8.5 Saudi Arabia Human Coagulation Factor VIII Market Size, 2016-2027
  6.8.6 UAE Human Coagulation Factor VIII Market Size, 2016-2027

7 MANUFACTURERS & BRANDS PROFILES

7.1 Shire (Baxter)
  7.1.1 Shire (Baxter) Corporate Summary
  7.1.2 Shire (Baxter) Business Overview
  7.1.3 Shire (Baxter) Human Coagulation Factor VIII Major Product Offerings
  7.1.4 Shire (Baxter) Human Coagulation Factor VIII Sales and Revenue in Global (2016-2021)
  7.1.5 Shire (Baxter) Key News
7.2 Bayer
  7.2.1 Bayer Corporate Summary
  7.2.2 Bayer Business Overview
  7.2.3 Bayer Human Coagulation Factor VIII Major Product Offerings
  7.2.4 Bayer Human Coagulation Factor VIII Sales and Revenue in Global (2016-2021)
  7.2.5 Bayer Key News
7.3 CSL
  7.3.1 CSL Corporate Summary
  7.3.2 CSL Business Overview
  7.3.3 CSL Human Coagulation Factor VIII Major Product Offerings
  7.3.4 CSL Human Coagulation Factor VIII Sales and Revenue in Global (2016-2021)
  7.3.5 CSL Key News
7.4 Pfizer
  7.4.1 Pfizer Corporate Summary
  7.4.2 Pfizer Business Overview
  7.4.3 Pfizer Human Coagulation Factor VIII Major Product Offerings
  7.4.4 Pfizer Human Coagulation Factor VIII Sales and Revenue in Global (2016-2021)
  7.4.5 Pfizer Key News
7.5 Grifols
  7.5.1 Grifols Corporate Summary
  7.5.2 Grifols Business Overview
  7.5.3 Grifols Human Coagulation Factor VIII Major Product Offerings
  7.5.4 Grifols Human Coagulation Factor VIII Sales and Revenue in Global (2016-2021)
  7.5.5 Grifols Key News
7.6 Biogen
  7.6.1 Biogen Corporate Summary
  7.6.2 Biogen Business Overview
  7.6.3 Biogen Human Coagulation Factor VIII Major Product Offerings
  7.6.4 Biogen Human Coagulation Factor VIII Sales and Revenue in Global (2016-2021)
  7.6.5 Biogen Key News
7.7 Octapharma
  7.7.1 Octapharma Corporate Summary
  7.7.2 Octapharma Business Overview
  7.7.3 Octapharma Human Coagulation Factor VIII Major Product Offerings
  7.4.4 Octapharma Human Coagulation Factor VIII Sales and Revenue in Global (2016-2021)
  7.7.5 Octapharma Key News
7.8 NovoNordisk
  7.8.1 NovoNordisk Corporate Summary
  7.8.2 NovoNordisk Business Overview
  7.8.3 NovoNordisk Human Coagulation Factor VIII Major Product Offerings
  7.8.4 NovoNordisk Human Coagulation Factor VIII Sales and Revenue in Global (2016-2021)
  7.8.5 NovoNordisk Key News
7.9 Greencross
  7.9.1 Greencross Corporate Summary
  7.9.2 Greencross Business Overview
  7.9.3 Greencross Human Coagulation Factor VIII Major Product Offerings
  7.9.4 Greencross Human Coagulation Factor VIII Sales and Revenue in Global (2016-2021)
  7.9.5 Greencross Key News
7.10 Kedrion
  7.10.1 Kedrion Corporate Summary
  7.10.2 Kedrion Business Overview
  7.10.3 Kedrion Human Coagulation Factor VIII Major Product Offerings
  7.10.4 Kedrion Human Coagulation Factor VIII Sales and Revenue in Global (2016-2021)
  7.10.5 Kedrion Key News
7.11 BPL
  7.11.1 BPL Corporate Summary
  7.11.2 BPL Human Coagulation Factor VIII Business Overview
  7.11.3 BPL Human Coagulation Factor VIII Major Product Offerings
  7.11.4 BPL Human Coagulation Factor VIII Sales and Revenue in Global (2016-2021)
  7.11.5 BPL Key News
7.12 Hualan Bio
  7.12.1 Hualan Bio Corporate Summary
  7.12.2 Hualan Bio Human Coagulation Factor VIII Business Overview
  7.12.3 Hualan Bio Human Coagulation Factor VIII Major Product Offerings
  7.12.4 Hualan Bio Human Coagulation Factor VIII Sales and Revenue in Global (2016-2021)
  7.12.5 Hualan Bio Key News
7.13 RAAS
  7.13.1 RAAS Corporate Summary
  7.13.2 RAAS Human Coagulation Factor VIII Business Overview
  7.13.3 RAAS Human Coagulation Factor VIII Major Product Offerings
  7.13.4 RAAS Human Coagulation Factor VIII Sales and Revenue in Global (2016-2021)
  7.13.5 RAAS Key News

8 GLOBAL HUMAN COAGULATION FACTOR VIII PRODUCTION CAPACITY, ANALYSIS

8.1 Global Human Coagulation Factor VIII Production Capacity, 2016-2027
8.2 Human Coagulation Factor VIII Production Capacity of Key Manufacturers in Global Market
8.3 Global Human Coagulation Factor VIII Production by Region

9 KEY MARKET TRENDS, OPPORTUNITY, DRIVERS AND RESTRAINTS

9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints

10 HUMAN COAGULATION FACTOR VIII SUPPLY CHAIN ANALYSIS

10.1 Human Coagulation Factor VIII Industry Value Chain
10.2 Human Coagulation Factor VIII Upstream Market
10.3 Human Coagulation Factor VIII Downstream and Clients
10.4 Marketing Channels Analysis
  10.4.1 Marketing Channels
  10.4.2 Human Coagulation Factor VIII Distributors and Sales Agents in Global

11 CONCLUSION

12 APPENDIX

12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
LIST OF TABLES

Table 1. Key Players of Human Coagulation Factor VIII in Global Market
Table 2. Top Human Coagulation Factor VIII Players in Global Market, Ranking by Revenue (2019)
Table 3. Global Human Coagulation Factor VIII Revenue by Companies, (US$, Mn), 2016-2021
Table 4. Global Human Coagulation Factor VIII Revenue Share by Companies, 2016-2021
Table 5. Global Human Coagulation Factor VIII Sales by Companies, (Kg), 2016-2021
Table 6. Global Human Coagulation Factor VIII Sales Share by Companies, 2016-2021
Table 7. Key Manufacturers Human Coagulation Factor VIII Price (2016-2021) & (USD/Kg)
Table 8. Global Manufacturers Human Coagulation Factor VIII Product Type
Table 9. List of Global Tier 1 Human Coagulation Factor VIII Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Human Coagulation Factor VIII Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 11. By Type – Global Human Coagulation Factor VIII Revenue, (US$, Mn), 2021 VS 2027
Table 12. By Type - Global Human Coagulation Factor VIII Revenue (US$, Mn), 2016-2021
Table 13. By Type - Global Human Coagulation Factor VIII Revenue (US$, Mn), 2022-2027
Table 14. By Type - Global Human Coagulation Factor VIII Sales (Kg), 2016-2021
Table 15. By Type - Global Human Coagulation Factor VIII Sales (Kg), 2022-2027
Table 16. By Application – Global Human Coagulation Factor VIII Revenue, (US$, Mn), 2021 VS 2027
Table 17. By Application - Global Human Coagulation Factor VIII Revenue (US$, Mn), 2016-2021
Table 18. By Application - Global Human Coagulation Factor VIII Revenue (US$, Mn), 2022-2027
Table 19. By Application - Global Human Coagulation Factor VIII Sales (Kg), 2016-2021
Table 20. By Application - Global Human Coagulation Factor VIII Sales (Kg), 2022-2027
Table 21. By Region – Global Human Coagulation Factor VIII Revenue, (US$, Mn), 2021 VS 2027
Table 22. By Region - Global Human Coagulation Factor VIII Revenue (US$, Mn), 2016-2021
Table 23. By Region - Global Human Coagulation Factor VIII Revenue (US$, Mn), 2022-2027
Table 24. By Region - Global Human Coagulation Factor VIII Sales (Kg), 2016-2021
Table 25. By Region - Global Human Coagulation Factor VIII Sales (Kg), 2022-2027
Table 26. By Country - North America Human Coagulation Factor VIII Revenue, (US$, Mn), 2016-2021
Table 27. By Country - North America Human Coagulation Factor VIII Revenue, (US$, Mn), 2022-2027
Table 28. By Country - North America Human Coagulation Factor VIII Sales, (Kg), 2016-2021
Table 29. By Country - North America Human Coagulation Factor VIII Sales, (Kg), 2022-2027
Table 30. By Country - Europe Human Coagulation Factor VIII Revenue, (US$, Mn), 2016-2021
Table 31. By Country - Europe Human Coagulation Factor VIII Revenue, (US$, Mn), 2022-2027
Table 32. By Country - Europe Human Coagulation Factor VIII Sales, (Kg), 2016-2021
Table 33. By Country - Europe Human Coagulation Factor VIII Sales, (Kg), 2022-2027
Table 34. By Region - Asia Human Coagulation Factor VIII Revenue, (US$, Mn), 2016-2021
Table 35. By Region - Asia Human Coagulation Factor VIII Revenue, (US$, Mn), 2022-2027
Table 36. By Region - Asia Human Coagulation Factor VIII Sales, (Kg), 2016-2021
Table 37. By Region - Asia Human Coagulation Factor VIII Sales, (Kg), 2022-2027
Table 38. By Country - South America Human Coagulation Factor VIII Revenue, (US$, Mn), 2016-2021
Table 39. By Country - South America Human Coagulation Factor VIII Revenue, (US$, Mn), 2022-2027
Table 40. By Country - South America Human Coagulation Factor VIII Sales, (Kg), 2016-2021
Table 41. By Country - South America Human Coagulation Factor VIII Sales, (Kg), 2022-2027
Table 42. By Country - Middle East & Africa Human Coagulation Factor VIII Revenue, (US$, Mn), 2016-2021
Table 43. By Country - Middle East & Africa Human Coagulation Factor VIII Revenue, (US$, Mn), 2022-2027
Table 44. By Country - Middle East & Africa Human Coagulation Factor VIII Sales, (Kg), 2016-2021
Table 45. By Country - Middle East & Africa Human Coagulation Factor VIII Sales, (Kg), 2022-2027
Table 46. Shire (Baxter) Corporate Summary
Table 47. Shire (Baxter) Human Coagulation Factor VIII Product Offerings
Table 48. Shire (Baxter) Human Coagulation Factor VIII Sales (Kg), Revenue (US$, Mn) and Average Price (USD/Kg) (2016-2021)
Table 49. Bayer Corporate Summary
Table 50. Bayer Human Coagulation Factor VIII Product Offerings
Table 51. Bayer Human Coagulation Factor VIII Sales (Kg), Revenue (US$, Mn) and Average Price (USD/Kg) (2016-2021)
Table 52. CSL Corporate Summary
Table 53. CSL Human Coagulation Factor VIII Product Offerings
Table 54. CSL Human Coagulation Factor VIII Sales (Kg), Revenue (US$, Mn) and Average Price (USD/Kg) (2016-2021)
Table 55. Pfizer Corporate Summary
Table 56. Pfizer Human Coagulation Factor VIII Product Offerings
Table 57. Pfizer Human Coagulation Factor VIII Sales (Kg), Revenue (US$, Mn) and Average Price (USD/Kg) (2016-2021)
Table 58. Grifols Corporate Summary
Table 59. Grifols Human Coagulation Factor VIII Product Offerings
Table 60. Grifols Human Coagulation Factor VIII Sales (Kg), Revenue (US$, Mn) and Average Price (USD/Kg) (2016-2021)
Table 61. Biogen Corporate Summary
Table 62. Biogen Human Coagulation Factor VIII Product Offerings
Table 63. Biogen Human Coagulation Factor VIII Sales (Kg), Revenue (US$, Mn) and Average Price (USD/Kg) (2016-2021)
Table 64. Octapharma Corporate Summary
Table 65. Octapharma Human Coagulation Factor VIII Product Offerings
Table 66. Octapharma Human Coagulation Factor VIII Sales (Kg), Revenue (US$, Mn) and Average Price (USD/Kg) (2016-2021)
Table 67. NovoNordisk Corporate Summary
Table 68. NovoNordisk Human Coagulation Factor VIII Product Offerings
Table 69. NovoNordisk Human Coagulation Factor VIII Sales (Kg), Revenue (US$, Mn) and Average Price (USD/Kg) (2016-2021)
Table 70. Greencross Corporate Summary
Table 71. Greencross Human Coagulation Factor VIII Product Offerings
Table 72. Greencross Human Coagulation Factor VIII Sales (Kg), Revenue (US$, Mn) and Average Price (USD/Kg) (2016-2021)
Table 73. Kedrion Corporate Summary
Table 74. Kedrion Human Coagulation Factor VIII Product Offerings
Table 75. Kedrion Human Coagulation Factor VIII Sales (Kg), Revenue (US$, Mn) and Average Price (USD/Kg) (2016-2021)
Table 76. BPL Corporate Summary
Table 77. BPL Human Coagulation Factor VIII Product Offerings
Table 78. BPL Human Coagulation Factor VIII Sales (Kg), Revenue (US$, Mn) and Average Price (USD/Kg) (2016-2021)
Table 79. Hualan Bio Corporate Summary
Table 80. Hualan Bio Human Coagulation Factor VIII Product Offerings
Table 81. Hualan Bio Human Coagulation Factor VIII Sales (Kg), Revenue (US$, Mn) and Average Price (USD/Kg) (2016-2021)
Table 82. RAAS Corporate Summary
Table 83. RAAS Human Coagulation Factor VIII Product Offerings
Table 84. RAAS Human Coagulation Factor VIII Sales (Kg), Revenue (US$, Mn) and Average Price (USD/Kg) (2016-2021)
Table 85. Human Coagulation Factor VIII Production Capacity (Kg) of Key Manufacturers in Global Market, 2019-2021 (Kg)
Table 86. Global Human Coagulation Factor VIII Capacity Market Share of Key Manufacturers, 2019-2021
Table 87. Global Human Coagulation Factor VIII Production by Region, 2016-2021 (Kg)
Table 88. Global Human Coagulation Factor VIII Production by Region, 2022-2027 (Kg)
Table 89. Human Coagulation Factor VIII Market Opportunities & Trends in Global Market
Table 90. Human Coagulation Factor VIII Market Drivers in Global Market
Table 91. Human Coagulation Factor VIII Market Restraints in Global Market
Table 92. Human Coagulation Factor VIII Raw Materials
Table 93. Human Coagulation Factor VIII Raw Materials Suppliers in Global Market
Table 94. Typical Human Coagulation Factor VIII Downstream
Table 95. Human Coagulation Factor VIII Downstream Clients in Global Market
Table 96. Human Coagulation Factor VIII Distributors and Sales Agents in Global Market

LIST OF FIGURES

Figure 1. Human Coagulation Factor VIII Segment by Type
Figure 2. Human Coagulation Factor VIII Segment by Application
Figure 3. Global Human Coagulation Factor VIII Market Overview: 2020
Figure 4. Key Caveats
Figure 5. Global Human Coagulation Factor VIII Market Size: 2021 VS 2027 (US$, Mn)
Figure 6. Global Human Coagulation Factor VIII Revenue, 2016-2027 (US$, Mn)
Figure 7. Human Coagulation Factor VIII Sales in Global Market: 2016-2027 (Kg)
Figure 8. The Top 3 and 5 Players Market Share by Human Coagulation Factor VIII Revenue in 2020
Figure 9. By Type - Global Human Coagulation Factor VIII Sales Market Share, 2016-2027
Figure 10. By Type - Global Human Coagulation Factor VIII Revenue Market Share, 2016-2027
Figure 11. By Type - Global Human Coagulation Factor VIII Price (USD/Kg), 2016-2027
Figure 12. By Application - Global Human Coagulation Factor VIII Sales Market Share, 2016-2027
Figure 13. By Application - Global Human Coagulation Factor VIII Revenue Market Share, 2016-2027
Figure 14. By Application - Global Human Coagulation Factor VIII Price (USD/Kg), 2016-2027
Figure 15. By Region - Global Human Coagulation Factor VIII Sales Market Share, 2016-2027
Figure 16. By Region - Global Human Coagulation Factor VIII Revenue Market Share, 2016-2027
Figure 17. By Country - North America Human Coagulation Factor VIII Revenue Market Share, 2016-2027
Figure 18. By Country - North America Human Coagulation Factor VIII Sales Market Share, 2016-2027
Figure 19. US Human Coagulation Factor VIII Revenue, (US$, Mn), 2016-2027
Figure 20. Canada Human Coagulation Factor VIII Revenue, (US$, Mn), 2016-2027
Figure 21. Mexico Human Coagulation Factor VIII Revenue, (US$, Mn), 2016-2027
Figure 22. By Country - Europe Human Coagulation Factor VIII Revenue Market Share, 2016-2027
Figure 23. By Country - Europe Human Coagulation Factor VIII Sales Market Share, 2016-2027
Figure 24. Germany Human Coagulation Factor VIII Revenue, (US$, Mn), 2016-2027
Figure 25. France Human Coagulation Factor VIII Revenue, (US$, Mn), 2016-2027
Figure 26. U.K. Human Coagulation Factor VIII Revenue, (US$, Mn), 2016-2027
Figure 27. Italy Human Coagulation Factor VIII Revenue, (US$, Mn), 2016-2027
Figure 28. Russia Human Coagulation Factor VIII Revenue, (US$, Mn), 2016-2027
Figure 29. Nordic Countries Human Coagulation Factor VIII Revenue, (US$, Mn), 2016-2027
Figure 30. Benelux Human Coagulation Factor VIII Revenue, (US$, Mn), 2016-2027
Figure 31. By Region - Asia Human Coagulation Factor VIII Revenue Market Share, 2016-2027
Figure 32. By Region - Asia Human Coagulation Factor VIII Sales Market Share, 2016-2027
Figure 33. China Human Coagulation Factor VIII Revenue, (US$, Mn), 2016-2027
Figure 34. Japan Human Coagulation Factor VIII Revenue, (US$, Mn), 2016-2027
Figure 35. South Korea Human Coagulation Factor VIII Revenue, (US$, Mn), 2016-2027
Figure 36. Southeast Asia Human Coagulation Factor VIII Revenue, (US$, Mn), 2016-2027
Figure 37. India Human Coagulation Factor VIII Revenue, (US$, Mn), 2016-2027
Figure 38. By Country - South America Human Coagulation Factor VIII Revenue Market Share, 2016-2027
Figure 39. By Country - South America Human Coagulation Factor VIII Sales Market Share, 2016-2027
Figure 40. Brazil Human Coagulation Factor VIII Revenue, (US$, Mn), 2016-2027
Figure 41. Argentina Human Coagulation Factor VIII Revenue, (US$, Mn), 2016-2027
Figure 42. By Country - Middle East & Africa Human Coagulation Factor VIII Revenue Market Share, 2016-2027
Figure 43. By Country - Middle East & Africa Human Coagulation Factor VIII Sales Market Share, 2016-2027
Figure 44. Turkey Human Coagulation Factor VIII Revenue, (US$, Mn), 2016-2027
Figure 45. Israel Human Coagulation Factor VIII Revenue, (US$, Mn), 2016-2027
Figure 46. Saudi Arabia Human Coagulation Factor VIII Revenue, (US$, Mn), 2016-2027
Figure 47. UAE Human Coagulation Factor VIII Revenue, (US$, Mn), 2016-2027
Figure 48. Global Human Coagulation Factor VIII Production Capacity (Kg), 2016-2027
Figure 49. The Percentage of Production Human Coagulation Factor VIII by Region, 2020 VS 2027
Figure 50. Human Coagulation Factor VIII Industry Value Chain
Figure 51. Marketing Channels


More Publications